Application of a targeted and quantificational foraminoplasty device in percutaneous transforaminal endoscopic discectomy for L5–S1 disc herniation: preliminary clinical outcomes

Abstract Objective Percutaneous transforaminal endoscopic discectomy (PTED) is minimally invasive and has been widely used to treat patients with lumbar disc herniation (LDH) due to its safety and efficiency. However, due to the unique anatomy of the L5–S1 level, the PTED procedure is often difficul...

Full description

Bibliographic Details
Main Authors: Jinlong Liu, Junlong Wu, Honglei Zhang, Rui Zuo, Jiabin Liu, Chao Zhang
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-021-02533-z
_version_ 1811280569904922624
author Jinlong Liu
Junlong Wu
Honglei Zhang
Rui Zuo
Jiabin Liu
Chao Zhang
author_facet Jinlong Liu
Junlong Wu
Honglei Zhang
Rui Zuo
Jiabin Liu
Chao Zhang
author_sort Jinlong Liu
collection DOAJ
description Abstract Objective Percutaneous transforaminal endoscopic discectomy (PTED) is minimally invasive and has been widely used to treat patients with lumbar disc herniation (LDH) due to its safety and efficiency. However, due to the unique anatomy of the L5–S1 level, the PTED procedure is often difficult to perform in the region. ZESSYS, a targeted and quantificational foraminoplasty device, may help to overcome these anatomical limitations. In this study, we assessed the efficiency and the short-term effects of PTED with ZESSYS at the L5–S1 level. Methods Between January and August of 2018, fifty-six patients with lumbar disc herniation at the single level of L5–S1 and who underwent percutaneous transforaminal endoscopic discectomy were enrolled in this retrospective cohort study. They were segregated into the transforaminal endoscopic surgical system (TESSYS) group and the ZESSYS group. The puncture time, foraminoplasty time, decompression time, and fluoroscopy time were evaluated for operation efficiency. Clinical outcomes were assessed by the visual analog scale (VAS) score and Oswestry Disability Index (ODI) score. The MacNab criteria were used to evaluate patient subjective satisfaction at 12-month follow-up postoperatively. Results The average puncture time (5.29 ± 2.05 min), foraminoplasty time (12.82 ± 2.52 min), and fluoroscopy time (26.29 ± 5.96 s) were all significantly shorter in the ZESSYS group than in the TESSYS group (average puncture time 8.07 ± 3.13 min, p < 0.01; foraminoplasty time, 17.18 ± 2.92 min, p < 0.01; fluoroscopy time, 34.73 ± 6.86 s; p < 0.01). No significant differences were observed between the 2 groups in the decompression time (p = 0.057). The VAS score of low back pain and leg pain, as well as the ODI score, improved at all time points postoperatively compared with preoperative, in both the TESSYS group and the ZESSYS group (P < 0.05). There were no significant differences in the VAS score of low back pain, VAS score of leg pain, and ODI score between the TESSYS group and the ZESSYS group at the same time points (P > 0.05). According to the MacNab criteria, the excellent and good rate at 12-month follow-up postoperatively was 85.7% in the TESSYS group and 89.3% in the ZESSYS group (P > 0.05). Conclusion The targeted and quantificational foraminoplasty device named ZESSYS was more efficient in the puncture and foraminoplasty procedures, effectively protecting the exiting nerve and minimizing the level of radiation exposure. The device is efficient and safe for PTED in treating lumbar disc herniation at the L5–S1 level.
first_indexed 2024-04-13T01:17:05Z
format Article
id doaj.art-e65ffe85e54f4d8aad07cab05092bad9
institution Directory Open Access Journal
issn 1749-799X
language English
last_indexed 2024-04-13T01:17:05Z
publishDate 2021-06-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj.art-e65ffe85e54f4d8aad07cab05092bad92022-12-22T03:08:54ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2021-06-011611910.1186/s13018-021-02533-zApplication of a targeted and quantificational foraminoplasty device in percutaneous transforaminal endoscopic discectomy for L5–S1 disc herniation: preliminary clinical outcomesJinlong Liu0Junlong Wu1Honglei Zhang2Rui Zuo3Jiabin Liu4Chao Zhang5Department of Spine Surgery, People’s Hospital of LiaochengDepartment of Orthopaedics, The 941th Hospital of Joint Logistics Support Force of Chinese PLADepartment of Spine Surgery, People’s Hospital of LiaochengDepartment of Spine Surgery, Xinqiao Hospital, Army Medical UniversityDepartment of Spine Surgery, Xinqiao Hospital, Army Medical UniversityDepartment of Spine Surgery, Xinqiao Hospital, Army Medical UniversityAbstract Objective Percutaneous transforaminal endoscopic discectomy (PTED) is minimally invasive and has been widely used to treat patients with lumbar disc herniation (LDH) due to its safety and efficiency. However, due to the unique anatomy of the L5–S1 level, the PTED procedure is often difficult to perform in the region. ZESSYS, a targeted and quantificational foraminoplasty device, may help to overcome these anatomical limitations. In this study, we assessed the efficiency and the short-term effects of PTED with ZESSYS at the L5–S1 level. Methods Between January and August of 2018, fifty-six patients with lumbar disc herniation at the single level of L5–S1 and who underwent percutaneous transforaminal endoscopic discectomy were enrolled in this retrospective cohort study. They were segregated into the transforaminal endoscopic surgical system (TESSYS) group and the ZESSYS group. The puncture time, foraminoplasty time, decompression time, and fluoroscopy time were evaluated for operation efficiency. Clinical outcomes were assessed by the visual analog scale (VAS) score and Oswestry Disability Index (ODI) score. The MacNab criteria were used to evaluate patient subjective satisfaction at 12-month follow-up postoperatively. Results The average puncture time (5.29 ± 2.05 min), foraminoplasty time (12.82 ± 2.52 min), and fluoroscopy time (26.29 ± 5.96 s) were all significantly shorter in the ZESSYS group than in the TESSYS group (average puncture time 8.07 ± 3.13 min, p < 0.01; foraminoplasty time, 17.18 ± 2.92 min, p < 0.01; fluoroscopy time, 34.73 ± 6.86 s; p < 0.01). No significant differences were observed between the 2 groups in the decompression time (p = 0.057). The VAS score of low back pain and leg pain, as well as the ODI score, improved at all time points postoperatively compared with preoperative, in both the TESSYS group and the ZESSYS group (P < 0.05). There were no significant differences in the VAS score of low back pain, VAS score of leg pain, and ODI score between the TESSYS group and the ZESSYS group at the same time points (P > 0.05). According to the MacNab criteria, the excellent and good rate at 12-month follow-up postoperatively was 85.7% in the TESSYS group and 89.3% in the ZESSYS group (P > 0.05). Conclusion The targeted and quantificational foraminoplasty device named ZESSYS was more efficient in the puncture and foraminoplasty procedures, effectively protecting the exiting nerve and minimizing the level of radiation exposure. The device is efficient and safe for PTED in treating lumbar disc herniation at the L5–S1 level.https://doi.org/10.1186/s13018-021-02533-zPercutaneous transforaminal endoscopic discectomyLumbar disc herniation at the L5–S1 levelForaminoplastyPreliminary clinical outcomes
spellingShingle Jinlong Liu
Junlong Wu
Honglei Zhang
Rui Zuo
Jiabin Liu
Chao Zhang
Application of a targeted and quantificational foraminoplasty device in percutaneous transforaminal endoscopic discectomy for L5–S1 disc herniation: preliminary clinical outcomes
Journal of Orthopaedic Surgery and Research
Percutaneous transforaminal endoscopic discectomy
Lumbar disc herniation at the L5–S1 level
Foraminoplasty
Preliminary clinical outcomes
title Application of a targeted and quantificational foraminoplasty device in percutaneous transforaminal endoscopic discectomy for L5–S1 disc herniation: preliminary clinical outcomes
title_full Application of a targeted and quantificational foraminoplasty device in percutaneous transforaminal endoscopic discectomy for L5–S1 disc herniation: preliminary clinical outcomes
title_fullStr Application of a targeted and quantificational foraminoplasty device in percutaneous transforaminal endoscopic discectomy for L5–S1 disc herniation: preliminary clinical outcomes
title_full_unstemmed Application of a targeted and quantificational foraminoplasty device in percutaneous transforaminal endoscopic discectomy for L5–S1 disc herniation: preliminary clinical outcomes
title_short Application of a targeted and quantificational foraminoplasty device in percutaneous transforaminal endoscopic discectomy for L5–S1 disc herniation: preliminary clinical outcomes
title_sort application of a targeted and quantificational foraminoplasty device in percutaneous transforaminal endoscopic discectomy for l5 s1 disc herniation preliminary clinical outcomes
topic Percutaneous transforaminal endoscopic discectomy
Lumbar disc herniation at the L5–S1 level
Foraminoplasty
Preliminary clinical outcomes
url https://doi.org/10.1186/s13018-021-02533-z
work_keys_str_mv AT jinlongliu applicationofatargetedandquantificationalforaminoplastydeviceinpercutaneoustransforaminalendoscopicdiscectomyforl5s1discherniationpreliminaryclinicaloutcomes
AT junlongwu applicationofatargetedandquantificationalforaminoplastydeviceinpercutaneoustransforaminalendoscopicdiscectomyforl5s1discherniationpreliminaryclinicaloutcomes
AT hongleizhang applicationofatargetedandquantificationalforaminoplastydeviceinpercutaneoustransforaminalendoscopicdiscectomyforl5s1discherniationpreliminaryclinicaloutcomes
AT ruizuo applicationofatargetedandquantificationalforaminoplastydeviceinpercutaneoustransforaminalendoscopicdiscectomyforl5s1discherniationpreliminaryclinicaloutcomes
AT jiabinliu applicationofatargetedandquantificationalforaminoplastydeviceinpercutaneoustransforaminalendoscopicdiscectomyforl5s1discherniationpreliminaryclinicaloutcomes
AT chaozhang applicationofatargetedandquantificationalforaminoplastydeviceinpercutaneoustransforaminalendoscopicdiscectomyforl5s1discherniationpreliminaryclinicaloutcomes